Pharmaceutical Contract Development And Manufacturing Market

1. Executive Summary
    1.1. Key Market Insights  

2. Introduction            
    2.1. Study Objectives        
    2.2. Market Definition        
           2.2.1. Market Covered    
           2.2.2. Regional Coverage    
           2.2.3. Study Years & Currency    
    2.3. Market Stakeholders        
    2.4. Key Questions this Study will Answer        
    2.5. GMI Research’s Approach & Methodology  
           2.5.1. Research Data
           2.5.2. Primary Data
           2.5.3. Demand Side and Supply Side Analysis
           2.5.4. Market Size Estimation
           2.5.5. Research Assumptions

3. Global Pharmaceutical Contract Development and Manufacturing Market- Overview            
    3.1. Introduction         
    3.2. Market Segmentation        
    3.3. Value Chain Analysis        
    3.4. Market Drivers        
    3.5. Market Restraints        
    3.6. Market Trends      

4. Global Pharmaceutical Contract Development and Manufacturing Market Revenue Forecast till 2030     

5. Global Pharmaceutical Contract Development and Manufacturing Market by Service Revenue Forecast till 2030            
    5.1. Pharmaceutical Manufacturing Devices
    5.2. Drug Development Services
    5.3. Biologics Manufacturing Devices

6. Global Pharmaceutical Contract Development and Manufacturing Market by End-User Revenue Forecast till 2030            
    6.1. Big Pharmaceutical Companies
    6.2. Small & Medium Sized Pharmaceutical Companies
    6.3. Generic Pharmaceutical Companies
    6.4. Others

7. Global Pharmaceutical Contract Development and Manufacturing Market by Region Forecast till 2030
    7.1. North America Pharmaceutical Contract Development and Manufacturing Market Revenue Forecast till 2030 
    (Option 1: As a part of the free 25% customization)
           7.1.1. North America Pharmaceutical Contract Development and Manufacturing Market by Service
                     7.1.1.1. Pharmaceutical Manufacturing Devices
                     7.1.1.2. Drug Development Services
                     7.1.1.3. Biologics Manufacturing Devices
           7.1.2. North America Pharmaceutical Contract Development and Manufacturing Market by End-User
                     7.1.2.1. Big Pharmaceutical Companies
                     7.1.2.2. Small & Medium Sized Pharmaceutical Companies
                     7.1.2.3. Generic Pharmaceutical Companies
                     7.1.2.4. Others
           7.1.3. US Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.1.4. Canada Pharmaceutical Contract Development and Manufacturing Market All-Up
    7.2. Europe Pharmaceutical Contract Development and Manufacturing Market Revenue Forecast till 2030 
    (Option 2: As a part of the free 25% customization)
           7.2.1. Europe Pharmaceutical Contract Development and Manufacturing Market by Service
                     7.2.1.1. Pharmaceutical Manufacturing Devices
                     7.2.1.2. Drug Development Services
                     7.2.1.3. Biologics Manufacturing Devices
           7.2.2. Europe Pharmaceutical Contract Development and Manufacturing Market by End-User
                     7.2.2.1. Big Pharmaceutical Companies
                     7.2.2.2. Small & Medium Sized Pharmaceutical Companies
                     7.2.2.3. Generic Pharmaceutical Companies
                     7.2.2.4. Others
           7.2.3. UK Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.2.4. Germany Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.2.5. France Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.2.6. Spain Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.2.7. Rest of Europe Pharmaceutical Contract Development and Manufacturing Market All-Up
    7.3. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Revenue Forecast till 2030 
    (Option 3: As a part of the free 25% customization) 
           7.3.1. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market by Service
                     7.3.1.1. Pharmaceutical Manufacturing Devices
                     7.3.1.2. Drug Development Services
                     7.3.1.3. Biologics Manufacturing Devices
           7.3.2. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market by End-User
                     7.3.2.1. Big Pharmaceutical Companies
                     7.3.2.2. Small & Medium Sized Pharmaceutical Companies
                     7.3.2.3. Generic Pharmaceutical Companies
                     7.3.2.4. Others
           7.3.3. China Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.3.4. India Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.3.5. Japan Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.3.6. Rest of APAC Pharmaceutical Contract Development and Manufacturing Market All-Up
    7.4. RoW Pharmaceutical Contract Development and Manufacturing Market Revenue Forecast till 2030
    (Option 4: As a part of the free 25% customization)  
           7.4.1. RoW Pharmaceutical Contract Development and Manufacturing Market by Service
                     7.4.1.1. Pharmaceutical Manufacturing Devices
                     7.4.1.2. Drug Development Services
                     7.4.1.3. Biologics Manufacturing Devices
           7.4.2. RoW Pharmaceutical Contract Development and Manufacturing Market by End-User
                     7.4.2.1. Big Pharmaceutical Companies
                     7.4.2.2. Small & Medium Sized Pharmaceutical Companies
                     7.4.2.3. Generic Pharmaceutical Companies
                     7.4.2.4. Others
           7.4.3. Brazil Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.4.4. South Africa Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.4.5. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.4.6. UAE Pharmaceutical Contract Development and Manufacturing Market All-Up
           7.4.7. Rest of world (remaining countries of the LAMEA region) Pharmaceutical Contract Development and Manufacturing Market All-Up

8. Competitive Landscape Analysis
    8.1. Porter’s Five Forces Analysis
    8.2. Industry – Competitive Landscape
    8.3. Market Presence (Intensity Mapping)
    8.4. Key Strategic Market Developments 

9. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
    9.1. Boehringer Ingelheim GmbH
           9.1.1. Company Overview    
           9.1.2. Key Executives 
           9.1.3. Footprint & Employee Strength 
           9.1.4. Product Offerings    
           9.1.5. Financials
           9.1.6. Key Company Developments 
    9.2. Lonza
           9.2.1. Company Overview    
           9.2.2. Key Executives   
           9.2.3. Footprint & Employee Strength
           9.2.4. Product Offerings
           9.2.5. Financials
           9.2.6. Key Company Developments
    9.3. Grifols S.A
           9.3.1. Company Overview    
           9.3.2. Key Executives
           9.3.3. Footprint & Employee Strength
           9.3.4. Product Offerings
           9.3.5. Financials
           9.3.6. Key Company Developments
    9.4. Jubilant Life Sciences Limited
           9.4.1. Company Overview    
           9.4.2. Key Executives
           9.4.3. Footprint & Employee Strength
           9.4.4. Product Offerings
           9.4.5. Financials
           9.4.6. Key Company Developments
    9.5. Pfizer, Inc. (Pfizer CenterOne)
           9.5.1. Company Overview    
           9.5.2. Key Executives   
           9.5.3. Footprint & Employee Strength
           9.5.4. Product Offerings
           9.5.5. Financials
           9.5.6. Key Company Developments
    9.6. Charles River Laboratories International, Inc.
           9.6.1. Company Overview    
           9.6.2. Key Executives
           9.6.3. Footprint & Employee Strength
           9.6.4. Product Offerings
           9.6.5. Financials
           9.6.6. Key Company Developments
    9.7. Albany Molecular Research, Inc.
           9.7.1. Company Overview
           9.7.2. Key Executives
           9.7.3. Footprint & Employee Strength
           9.7.4. Product Offerings
           9.7.5. Financials
           9.7.6. Key Company Developments    
    9.8. Covance, Inc. (LabCorp)
           9.8.1. Company Overview
           9.8.2. Key Executives 
           9.8.3. Footprint & Employee Strength
           9.8.4. Product Offerings
           9.8.5. Financials
           9.8.6. Key Company Developments    
    9.9. QuintilesIMS
           9.9.1. Company Overview
           9.9.2. Key Executives 
           9.9.3. Footprint & Employee Strength
           9.9.4. Product Offerings
           9.9.5. Financials
           9.9.6. Key Company Developments   
    9.10. Baxter BioPharma Solutions
           9.10.1. Company Overview
           9.10.2. Key Executives 
           9.10.3. Footprint & Employee Strength
           9.10.4. Product Offerings
           9.10.5. Financials
           9.10.6. Key Company Developments   

10. About GMI Research

*Details on Financials might not be available in case of unlisted/private companies.

*The list of companies is based on preliminary research in this sample report, the companies in the final report may change based on research findings.